RxDoctor Payments Data

Alan Berman, DPM

Podiatrist · Carmel, NYNPI 1538146352

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $7,746 of the $12,245 with a category attached, or 63.3%. Treace Medical Concepts, Inc. accounts for 80.0% of it on its own, with 22 other manufacturers making up the rest. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,245in general payments, 2019–2025

Across 119 payments — averaging $102.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$10K
  • Smith+Nephew$411
  • Organogenesis Inc.$339
  • Misonix Inc$228
  • Bioventus LLC$219
  • Stryker$190
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$7,74663%
  • Food & beverage$4,27035%
  • Education$400%
  • Gifts$1902%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,245 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$126,495
Medicare patients
407
Services billed
1,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin18$106
Meloxicam13$68
Oxycodone Hcl11$28
Gabapentin15$24

Paid to pharmacies, not to this prescriber.

Other podiatrist in Carmel

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →